Skip to main content
Livermore
Livermore
ZHEN

SG Americas Securities, LLC

SEC CIK
0001313360
Latest filing
Aug 7, 2026

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by SG Americas Securities, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overviewAll 13F holders of APLSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of APLS by SG Americas Securities, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−29,601−100.0%Sold outHolders
Q1 202629,601$1.19M<0.1%−537,445−94.8%ReducedHolders
Q4 2025567,046$14.2M<0.1%+149,654+35.9%AddedHolders
Q3 2025417,392$9.45M<0.1%+372,289+825.4%AddedHolders
Q2 202545,103$781.0K<0.1%−321,041−87.7%ReducedHolders
Q1 2025366,144$8.01M<0.1%+313,743+598.7%AddedHolders
Q4 202452,401$1.67M<0.1%+28,932+123.3%AddedHolders
Q3 202423,469$677.0K<0.1%−84,092−78.2%ReducedHolders
Q2 2024107,561$4.13M<0.1%+60,026+126.3%AddedHolders
Q1 202447,535$2.79M<0.1%−1,366−2.8%ReducedHolders
Q4 202348,901$2.93M<0.1%−125,668−72.0%ReducedHolders
Q3 2023174,569$6.64M0.1%+73,458+72.7%AddedHolders
Q2 2023101,111$9.21M0.1%+90,048+814.0%AddedHolders
Q1 202311,063$730.0K<0.1%−20,319−64.7%ReducedHolders
Q4 202231,382$1.62M<0.1%+3,520+12.6%AddedHolders
Q3 202227,862$1.90M<0.1%−23,894−46.2%ReducedHolders
Q2 202251,756$2.34M<0.1%+47,611+1,148.6%AddedHolders
Q1 20224,145$211.0K<0.1%−173,589−97.7%ReducedHolders
Q4 2021177,734$8.40M0.1%−6,280−3.4%ReducedHolders
Q3 2021184,014$6.07M<0.1%+159,061+637.4%AddedHolders
Q2 202124,953$1.58M<0.1%+7,142+40.1%AddedHolders
Q1 202117,811$764.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.